The flotation of US-based liver drugs maker Intercept Pharmaceuticals, majority owned by Genextra, came in October.

Mergent, a US-based provider of business and financial data on listed companies backed by investment bank Goldman Sachs, has sold its dividend index business to stock exchange provider Nasdaq OMX Group for an undisclosed amount.

Reed Elsevier Ventures owns 18.3%.

YY would have an initial market capitalisation of $2.9bn at $11.50 per share.

Shionogi owns 12.5% of Enanta before its initial public offering, while Abbott Labs has 8.38%.

WiFi equipment maker Ruckus Wireless has set an initial public offering range of $13 per share to $15 per share and expects to sell 8.4m shares of stock.

Wintech owned a 7.3% stake, or 1.5 million shares, ahead of the flotation, which went down to 4.8% post the IPO.

Zurich Financial Services Group, Edison and private equity firm Ticonderoga Capital backed the provider of clinical and regulatory information management services' $10m C round in 2006.

Regulus Therapeutics has raised $80.9m in total proceeds from its initial public offering, a private placement, and convertible note.